Application 090081
- Type
- ANDA
- Sponsor
- MAYNE PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE; ETHINYL ESTRADIOL | TABLET;ORAL-28 | 3MG;0.03MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51862-036 | Zarah | Drospirenone and Ethinyl Estradiol | Mayne Pharma Inc. | ANDA | Current |
| 51862-036 | Zarah | Drospirenone and Ethinyl Estradiol | Mayne Pharma Inc. | ANDA | Current |
| 52544-981 | Zarah | Drospirenone and Ethinyl Estradiol | Actavis Pharma, Inc. | ANDA | Current |
| 53002-1627 | Zarah | Drospirenone and Ethinyl Estradiol | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-1627 | Zarah | Drospirenone and Ethinyl Estradiol | RPK Pharmaceuticals, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 31449 | ORIG | 2010-03-22 |